Worldwide Multiple Myeloma Treatment Industry to 2029 - Players Include Janssen Biotech, Bristol-Myers Squibb and Novartis Among Others Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Multiple Myeloma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...

Leukapheresis Market by Product, Leukopak, Indication, Application, End-user - Global Forecast to 2026 Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple...

Norton Healthcare enrolls first patient in world for COVID-19 drug trial Louisville, KY, April 21, 2020 (GLOBE NEWSWIRE) -- A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor....

New Report Demonstrates Potential for Cell and Gene Therapies to Provide Cost Savings WASHINGTON, D.C., Jan. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the cell and gene...

Patient Advocate Foundation Launches Transportation Grant for Multiple Myeloma Patients HAMPTON, Va., April 4, 2016 (GLOBE NEWSWIRE) -- In 2015, Patient Advocate Foundation (PAF) found that 15% of patients assisted by their case management department reported access to care issues due to...